BIOMAT Database Logo BIOMAT Database Logo

Synthesis, Src kinase inhibitory and anticancer activities of 1-substituted 3-(N-alkyl-N-phenylamino)propane-2-ols. 2010

Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Bioorganic Laboratory, Department of Chemistry, University of Delhi, Delhi 110 007, India.

A series of 3-(N-alkyl-N-phenylamino)propan-2-ol derivatives were synthesized from epichlorohydrine in a multi-step strategy and were evaluated as Src kinase inhibitors. First, epoxy ring opening of epichlorohydrine was carried out in the presence of N-alkylanilines to yield 3-(N-alkyl-N-phenylamino)-1-chloro-propan-2-ol derivatives using Ca(OTf)2 as catalyst based on our previous studies [1]. Second, ring closure was performed under basic conditions to afford N-epoxymethyl N-alkylaniline derivatives. Finally, the epoxide ring opening with four different secondary amines and three nucleobases afforded the final products, i.e., a series of beta-amino alcohols. All compounds were screened for their inhibitory activity against Src kinase and anticancer activity on human breast carcinoma cells, BT-20 cell line. Among all compounds, 3-N-methyl-N-phenylamino-1-(pyrrolidin-1-yl)propan-2-ol (13b) exhibited the highest inhibitory potency (IC50=66.1 microM) against Src kinase. Structure-activity relationship studies suggested that the incorporation of bulky groups at position 1 and N-substitution with groups larger than methyl moiety, reduced the inhibitory potency of the compound significantly. Compounds 3-(N-ethyl-N-phenylamino-)-1-(4-methylpiperazin-1-yl)propan-2-ol (14c) and 3-(N-ethyl-N-phenylamino)-1-(thymine-1-yl)propan-2-ol (17) were found to inhibit the growth of breast carcinoma cells by approximately 45-49% at concentration of 50 microM.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000605 Amino Alcohols Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2). Alcohols, Amino
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D019061 src-Family Kinases A PROTEIN-TYROSINE KINASE family that was originally identified by homology to the Rous sarcoma virus ONCOGENE PROTEIN PP60(V-SRC). They interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. Oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes. Protein-Tyrosine Kinases, src,Src Family Tyrosine Kinase,src Kinase,src Kinases,src Tyrosine Kinase,src-Family Kinase,src-Family Tyrosine Kinase,src Tyrosine Kinases,src-Family Tyrosine Kinases,Kinase, src,Kinase, src Tyrosine,Kinase, src-Family,Kinase, src-Family Tyrosine,Kinases, src,Kinases, src Protein-Tyrosine,Kinases, src Tyrosine,Tyrosine Kinase, src,Tyrosine Kinase, src-Family,Tyrosine Kinases, src,Tyrosine Kinases, src-Family,src Family Kinase,src Family Kinases,src Family Tyrosine Kinases,src Protein-Tyrosine Kinases
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities.
October 2011, European journal of medicinal chemistry,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Synthesis and Src kinase inhibitory activity of a series of 4-phenylamino-3-quinolinecarbonitriles.
March 2001, Journal of medicinal chemistry,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
3-substitued indoles: one-pot synthesis and evaluation of anticancer and Src kinase inhibitory activities.
June 2011, Bioorganic & medicinal chemistry letters,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities.
March 2011, Bioorganic & medicinal chemistry letters,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
March 1983, Journal of medicinal chemistry,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities.
September 2011, Medicinal chemistry (Shariqah (United Arab Emirates)),
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Synthesis of 2-(N-arylcarboxamide)-3-substituted ethoxyindoles and their monoamine oxidase inhibitory and anticonvulsant activities.
June 1975, Journal of pharmaceutical sciences,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Central cholinergic agents. II. Synthesis and acetylcholinesterase inhibitory activities of N-[omega-[N-alkyl-N-(phenylmethyl)amino]alkyl]-3-arylpropenamides.
December 1991, Chemical & pharmaceutical bulletin,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Synthesis and evaluation of anticancer activities of 2- or 4-substituted 3-(N-benzyltriazolylmethyl)-13α-oestrone derivatives.
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Deepti Sharma, and Raman K Sharma, and Sumati Bhatia, and Rakesh Tiwari, and Deendayal Mandal, and Jessica Lehmann, and Keykavous Parang, and Carl E Olsen, and Virinder S Parmar, and Ashok K Prasad
Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
June 2009, Archiv der Pharmazie,
Copied contents to your clipboard!